Shares of Leap Therapeutics (LPTX) climbed 25% aft the microcap crab cause developer announced a $58.9 cardinal backstage concern led by Winklevoss Capital to kickstart a crypto treasury strategy.

The investment, structured arsenic a backstage placement, includes communal shares and warrants priced astatine $0.61439 per unit. Winklevoss Capital, founded by Cameron and Tyler Winklevoss, volition besides summation 2 committee seats astatine Leap.

Exactly which cryptos would beryllium purchased was not disclosed.

Leap, known for its immuno-oncology therapies, said it volition usage a information of the superior to acquisition cryptocurrency arsenic portion of a longer-term program to clasp crypto connected its equilibrium sheet. The remainder volition enactment objective improvement of its cause candidates.

The woody places Leap among a increasing database of nationalist companies utilizing crypto arsenic a treasury reserve. Leap said much details connected its integer plus strategy volition beryllium announced successful the adjacent aboriginal and didn’t item which assets it plans connected acquiring.

Shares were higher by 25% successful Monday greeting trade.